AR241574A1 - Procedimiento para preparar una nueva composicion farmaceutica para tratar la insuficiencia cardiaca. - Google Patents

Procedimiento para preparar una nueva composicion farmaceutica para tratar la insuficiencia cardiaca.

Info

Publication number
AR241574A1
AR241574A1 AR87308402A AR30840287A AR241574A1 AR 241574 A1 AR241574 A1 AR 241574A1 AR 87308402 A AR87308402 A AR 87308402A AR 30840287 A AR30840287 A AR 30840287A AR 241574 A1 AR241574 A1 AR 241574A1
Authority
AR
Argentina
Prior art keywords
view
salts acceptable
pharmaceutical preparation
physiological point
inotroped
Prior art date
Application number
AR87308402A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of AR241574A1 publication Critical patent/AR241574A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UNA NUEVA COMPOSICION FARMACEUTICA PARA TRATAR LA INSUFICIENCIA CARDIACA, PORQUE SE TRANSFORMA POR LO MENOS UNA 2-ARIL- IMIDAZO (4,5B) O (4,5-C)PIRIDINA DE ACCION INOTROPA POSITIVA, Y/O POR LO MENOS UNA DE SUS SALES ACEPTABLES DESDE EL PUNTO DE VISTA FISIOLOGICO, JUNTO CON POR LO MENOS UN INHIBIDOR DE LA ENZIMA CONVERSORA DE LA ANGIOTENSINA (ECA), Y/O UNA DE SUS SALES ACEPTABLES DESDE EL PUNTO DE VISTA FISIOLOGICO, CON POR LO MENOS UN EXCIPIENTE O SUSTANCIA AUXILIAR, EN UNA FORMA DE PRESENTACION FARMACEUTICA APROPIADAMENTE DOSIFICABLE.
AR87308402A 1986-08-14 1987-08-11 Procedimiento para preparar una nueva composicion farmaceutica para tratar la insuficiencia cardiaca. AR241574A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863627613 DE3627613A1 (de) 1986-08-14 1986-08-14 Pharmazeutische zubereitung

Publications (1)

Publication Number Publication Date
AR241574A1 true AR241574A1 (es) 1992-09-30

Family

ID=6307397

Family Applications (1)

Application Number Title Priority Date Filing Date
AR87308402A AR241574A1 (es) 1986-08-14 1987-08-11 Procedimiento para preparar una nueva composicion farmaceutica para tratar la insuficiencia cardiaca.

Country Status (5)

Country Link
EP (1) EP0256402A3 (es)
KR (1) KR880002521A (es)
AR (1) AR241574A1 (es)
DE (1) DE3627613A1 (es)
ZA (1) ZA876048B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
CA2021408A1 (en) * 1989-08-31 1991-03-01 Luana R. C. Moore Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3139064A1 (de) * 1981-10-01 1983-04-14 Merck Patent Gmbh, 6100 Darmstadt 2-aryl-imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR880002521A (ko) 1988-05-09
DE3627613A1 (de) 1988-02-18
EP0256402A2 (de) 1988-02-24
ZA876048B (en) 1988-04-27
EP0256402A3 (de) 1989-09-20

Similar Documents

Publication Publication Date Title
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
ATE109971T1 (de) Verabreichung von arzneimitteln über die lungen.
NO990916D0 (no) Bruk av GLP-1 eller analoger i behandlingen av myokardialt infarkt
ES2081102T5 (es) Vacuna para el herpes simple compuesta por glicoproteina gd del hsv y lipido a de monofosforilo 3-desacilado.
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
ES537769A0 (es) Protesis cardiaca total que incluye dos bombas desacopladas asociadas en una unidad funcional indisociable
SE8202172L (sv) Topiska farmaceutiska kompositioner
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
NL192822B (nl) In compartimenten verdeelde pleisters voor transdermale en dermale toediening.
IT8721672A0 (it) Procedimento per la protezione di filetti maschio e femmina coniugati.
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
EP0151989A3 (en) Means for the treatment of cardiac diseases
ES2063033T3 (es) Empleo de igf-ii en el tratamiento de la enfermedades de los huesos.
ES2041681T3 (es) Tratamiento de infecciones fungosas.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
AU531878B2 (en) Medicated animal feed based on liver meal
ES2051754T3 (es) Uso de derivados cetonicos en el tratamiento de la depresion.
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
AR241574A1 (es) Procedimiento para preparar una nueva composicion farmaceutica para tratar la insuficiencia cardiaca.
ES2034953T3 (es) Un procedimiento para la preparacion de una tiazolona.
ES2043614T3 (es) Procedimiento para la preparacion de un compuesto bactericida.
ES2051709T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica para uso parenteral que contiene calcitonina como el ingrediente activo.
EA199700150A1 (ru) КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC
DE3776111D1 (de) Pharmazeutische zubereitungen.